E-DRUG: USP - Pandemic Preparedness for Regulators in LMICs
----------------------------------------------------------------------------------
[E-DRUG will spend some extra energy in these difficult Corona times with providing information about potential treatments of COVID-19 patients in low- and middle-income countries. Although the media focus is now on Europe and USA, we know that Africa, Asia and Latin America will be hard hit in the next wave!
USP has posted in E-DRUG before, and their reports and messages are very welcome!
E-druggers working in the field are welcome to send questions and experiences to e-drug@healthnet.org WB]
Dear E-Druggers,
Recently, USP has issued a new COVID-related document
Pandemic Preparedness for Regulators in Low- and Middle-Income Countries: Mitigating medical product shortages, preparing the public, and protecting patients during the COVID-19 pandemic and beyond.
There are some other material related COVID19 activities on this webpage titled “USP - Supporting the public health response to COVID-19” that may be worth following for updates:
https://www.usp.org/about/public-policy/covid-19
I hope that you can share this widely!
Best,
Nagesh
Nagesh N. Borse
Director, Global Public Health
USP
12601 Twinbrook Parkway
Rockville, MD 20852
USA
Office : TB1-4-026A
Phone: +1-301-692-3647
Nagesh Borse <nagesh.borse@USP.org>